Phase 1b trial finds tetravalent E coli bioconjugate vaccine candidate in women with recurrent UTI safe and immunogenic.
Researchers discover a gene variant of MCR-1 from the rectal swab of a leukemic child
May be first case in the United States.
Case presented of patient with extended-spectrum beta-lactamase E. coli infection.
A study has found that the rate of ESBL-E. coli infections increased from 5.28 to 10.5 per 100,000 patients between 2009 and 2014.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- The Misuse of Antibiotics in Acute Pancreatitis Appears Widespread
- ART Reduces Neurocognitive Impairment in Patients Living With HIV
- Tackling the Challenges Associated With Treating Hepatitis C Infection in Pediatric Patients
- Mental Health Problems in Adolescents With HIV: Overview & Expert Interview
- Severity of Acute Respiratory Infections in Children Affected by Viral Etiology
- Antibiotic Prophylaxis Before Dental Procedures May Be Unnecessary
- Penicillin Allergies: Commonly Reported but Rarely Accurate
- Irritable Bowel Syndrome Treatments
- Oral Ciprofloxacin Effective in Treatment for Bacteremia
- Need for Adequate Screening for Infants With HCV Infected Mothers During Pregnancy
- Patient Develops Glandular Tularemia After Taking Care of Sick Cat
- Internet-Based Intervention Can Reduce Depression in People Living With HIV
- Prophylaxis With TMP-SMX Did Not Alter Risk for Non-UTI Infections
- Low Recurrence With Shortened IV Abx Course in GBS Bacteremia
- Renal-Replacement Timing Has No Effect in Kidney Injury, Sepsis